Central nervous system effects of Ginkgo biloba, a plant extract

American Journal of Therapeutics

Volumn 3, Issue 1, 1996, Pages 63-73

  Itil, Turan M ^a,d   Eralp, Emin ^b   Tsambis, Elias ^c   Itil, Kurt Z ^b   Stein, Ulrich ^c  

^a New York Inst for Medical Research   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c HZI Research Center Inc   (United States)

^d NONE   (United States)

Author keywords

bioavailability; cognitive activators; dementia; Ginkgo biloba extract; pharmacodynamic; quantitative pharmaco EEG; tacrine

Indexed keywords

DIHYDROERGOTOXINE MESILATE; GINKGO BILOBA EXTRACT; TACRINE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; CLINICAL TRIAL; COGNITION; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG FORMULATION; ELECTROENCEPHALOGRAM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029924197     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199601000-00009     Document Type: Article

References (62)

1. Kleijnen J, Knipschild P: Lancet 1992;340:1136.
2. DeFeudis FV (Ed.): Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, Elsevier, Paris, 1991.
3. The International Classification of Diseases, 10th Revision. World Health Organization, Geneva, 1994.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC, 1994.
5. Oesterreich K, Hoyer S: Medwelt 1989;40:1218.
6. Ulmar G: Dtsch Med Wschr 1991;116:584.
7. Gutzmann H, Richert A, Dahlke F: Zeitschr Gerontopsychol Psychiatrie 1992;5:165.
8. Kleijnen J, Knipschild P: Br J Clin Pharmacol 1992;34:352.
9. Schmidt U, Rabinovici K, Lande S: Munch Med Wochenschr 1991;133:S15.
10. Bruchert E, Heinrich SE, Ruf-Kohler P: Munch Med Wochenschr 1991;133:S9.
11. Wesnes K, Simmons D, Rook M, Simpson P: Hum Psychopharmacol 1987;2:159.
12. Hofferberth B: Arzneimittelforschung 1989;39:918.
13. Hofferberth B: Munch Med Wochenschr 1991;133:S30.
14. Bundes Anzeiger No. 133, VI a/414 (1994).
15. Fed Reg 1975;40:26157.
16. Final Task Force Report on Bioavailability and Bioequivalency of Psychotropic Drugs: Psychopharmacol Bull 1980;16:9.
17. Itil TM: In: Psychotropic Drugs and the Human EEG (Ed. Itil TM) Karger, Basel, 1974, pp. 43-75.
18. Itil TM, Eralp E, Mucci A, Siegal S: In: Dose-Response Relationship of Drugs (Eds. Kuhlmann J, Wingender, W), W. Zuckschwerdt Verlag, Munchen, 1990, pp. 157-167.
19. Fink M: In: Psychotropic Drugs and the Human EEG (Ed. Itil TM) Karger, Basel, 1974, pp. 76-98.
20. Itil TM, Itil KZ: J Clin Psychiat 1986;47:20.
21. Itil TM, Cabana B, Purich E, Songar A, Eralp E: Integrative Psychiatry 1985;3:23S.
22. Report of The Committee for "Geriatric diseases and asthenias" at BGA, 1986.
23. Matejcek M, Knor K, Piguet PV, Weil C: J Am Geriatr Soc 1979;27:198.
24. Alhainen K, Partanen J, Reinikainen K, Laulumaa V, Soininen H, Airaksinen M, Reikkinen P: Neurosci Lett 1991;127:113.
25. Itil TM, Menon G: Proceedings of the World Congress of Clinical Pharmacology and Therapeutics, 1980, Vol. 1, p. 975.
26. Shapiro DM, Itil TM, Huque MF, Forbes D: Electroenceph Clin Neurophysiol. 1977;43:553.
27. Itil TM, Mucci A, Eralp E: Int J Psychophysiol 1991;10: 281.
28. Scheffe H: The Analysis of Variance, John Wiley & Sons, New York, 1967.
29. Itil TM, Soldatos C, Bozak M, Ramadanoglu E, Dayican G, Morgan V, Menon GN: Curr Therap Res 1979;26:525.
30. Bente D, Glatthaar G, Ullrich G, Lewinsky M: Arzneimittelforsch 1978;28:1529.
31. Saletu B, Grunberger J: Prog Neuropsychopharmacol 1980;4:469.
32. Herrmann WM, Kubicki SK, Rohmel J: Zeitschr Gerontopsychol Psychiatrie 1988;1:1.
33. Itil TM: In: Recent Advances in Biological Psychiatry (Ed. Wortis J), Plenum Press, New York, 1966, pp. 151-173.
34. Itil TM, Fink M: J Nerv Mental Dis 1966;143:492.
35. Fink M: Clin Neurophysiol 1960;12:359.
36. Bradley BP, Elkes J: J Physiol 1953;120:14-15.
37. Katz RI, Harner RN: In: Clinical Neurology of Aging (Ed. Albert ML), Oxford University Press, New York, 1984, pp. 114-138.
38. Pollock VE, Schneider LS, Lyness SA: Electroenceph Clin Neurophysiol 1991;79:20.
39. Cohen L, Danzinger W, Storaudt M: Electroenceph Clin Neurophysiol 1985;61:101.
40. Penttila M, Partanen JV, Soininen H, Riekkinen PJ: Electroencephalogr Clin Neurophysiol 1985;60:1.
41. Ihl R, Maurer K, Dierks T, Froehlich L, Perisic I: Psychiatry Res 1989;29:399.
42. Duffy FH, Albert MS, McAnulty G: Ann Neurol 1984;16: 439.
43. Prichep L, Gomex Mont F, John ER, Ferris SM: In: Alzheimer's Disease: The Standard Reference (Ed. Reisberg B), Free Press, New York, 1983.
44. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR: Science 1982;215:1237.
45. Riekkinen PJ, Riekkinen PJ Jr, Soininen H, Reinikainen K, Laulumaa V, Partanen J, Halonen T, Paljarvi L: In: Alzheimer's Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics (Eds. Maurer K, Riederer P, Beckmann H), Springer-Verlag, Vienna, 1990, pp. 437-445.
46. Riekkinen PJ, Soininen H et al: Neurology 1989;38(Suppl 1):170.
47. Montplaisir JY: Electroenceph Clin Neurophysiol 1975;38: 272.
48. Steriade M, McCormick DA, Sejnowski TJ: Science 1993; 262:679.
49. Steriade M, Datta S, Pare D, Oakson G, Curro Dossi R: J Neurosci 1990;10:2541;
50. Steriade M, Datta S, Pare D, Oakson G, Curro Dossi R: J Neurosci 10:2560.
51. Rainnie DG, Grunze HCR, McCarley RW, Greene RW: Science 1994;263:689.
52. Kunkel H: Neuropsychobiology 1993;27:40.
53. Gessner B, Volp A, Klasser M: Arzneimittelforschung 1985;2:35.
54. Pidoux B, Bastien C, Niddam S: J Cerebr Blood Flow Metab 1983;3:5556.
55. Sitzer G: Kassenarzt 1987;27:28.
56. Taylor JE: Presse Med 1986;15:1491.
57. Rapin JR, Franchet S, Drieu K: In: Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications (Ed. DeFeudis FV) Elsevier, Paris, 1991.
58. Weinbrecht WV, Jansen W: Fortschr Med 1986;104:199-202.
59. Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R: Proceedings of the 6th Congress of the International Psychogeriatric Association, 1993;
60. Ihl R, Dierks T, Martin E, Frolich L, Maurer K: 15th Danube Symposium of Psychiatry, 1992.
61. Itil TM, Itil KZ, Eralp E, Mucci A, Vaid G: In: Psychogeriatrics Biomedical and Social Advances (Eds. Hasagawa K, Homma A), (Excerpta Medica, 1990, pp. 384-398.
62. Ferradini C, Droy-Lefaix MT, Christen Y (Eds.), Ginkgo Biloba Extract (EGb 761) as a Free-Radical Scavenger (Elsevier, Paris, 1993).